OncoSil Medical Limited (ASX:OSL)
Australia · Delayed Price · Currency is AUD 1.245
+0.035 (2.89%)
Aug 7, 2026, 4:10 PM AEST
OncoSil Medical Market Cap
OncoSil Medical has a market cap or net worth of 38.46 million as of August 7, 2026. Its market cap has increased by 88.29% in one year.
Market Cap
38.46M
Enterprise Value
35.65M
Revenue
3.72M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.25
ChartMarket Cap Chart
Since August 15, 2005, OncoSil Medical's market cap has increased from 7.29M to 38.46M, an increase of 427.20%. That is a compound annual growth rate of 8.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 38.46M | 109.86% |
| Dec 31, 2025 | 18.33M | -33.55% |
| Dec 31, 2024 | 27.58M | 55.21% |
| Dec 28, 2023 | 17.77M | -60.28% |
| Dec 30, 2022 | 44.74M | 25.48% |
| Dec 31, 2021 | 35.65M | -63.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cyclopharm | 69.97M |
| Epiminder | 69.23M |
| Cleo Diagnostics | 45.25M |
| Compumedics | 44.95M |
| Nova Eye Medical | 42.73M |
| HeraMED | 39.35M |
| CleanSpace Holdings | 31.56M |
| Control Bionics | 30.73M |